Dr. David J. Gross, MD

Dr. Gross practices at Suncoast Skin Solutions in Saint Augustine, Florida.

Dr. Gross' NPI, 1346225828, was assigned on December 7, 2005. Dr. Gross graduated from New York Medical College in 1984. Dr. Gross holds Florida license ME62729.

Dr. Gross' primary practice is Suncoast Skin Solutions, at 1100 S Ponce De Leon Blvd Ste 3b, Saint Augustine, FL 32084-6013. The practice phone is (904) 823-9992.

Dr. Gross' primary practice is Suncoast Skin Solutions in Saint Augustine, Florida. Dr. Gross is also affiliated with UF Health Flagler Hospital. The medical group on file is Suncoast Skin Solutions. Dmand AI also links Dr. Gross to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gross practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Gross' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gross is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Gross' licenses on file in 2 states: Florida and Georgia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Gross treats.

CMS data shows 7,660 Medicare services from Dr. Gross across 29 procedure codes in 2024, for 1,691 Medicare patients. Medicare paid $351,123 for them. Every service was in an office.

CMS counts 1,691 Medicare patients who saw Dr. Gross in 2024. The largest group is 75 to 84, with 733 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gross' median patient age at 77, with 41% women.

In 2024, Dr. Gross wrote 998 Medicare Part D claims for 472 patients. 93% of them were for generic drugs. CMS names the drug for 815 of them, across 21 drugs with 11 or more claims each, at $208,527 in total drug cost. In 2023, CMS named 757 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gross for performance year 2024, reported individually. Dr. Gross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 620 procedures of removal or shaving of skin growth by Dr. Gross, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 131 papers to Dr. Gross, published from 2001 to 2011. 2010 was the busiest year, with 6. The most frequent topics are Insulin, Islets of Langerhans and Calcium. Dr. Gross has published most often in Diabetes. Dr. Gross' most frequent co-authors are Sarah Kay Barksdale, MD, Frank Gonzalez, MD and Douglas Gross, MD.

CMS Open Payments shows 558 general payments to Dr. Gross from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $3,559.

Dmand AI lists 1 award for Dr. Gross.

Dr. Gross graduated from New York Medical College in 1984. Dr. Gross is a member of AAD.

Dr. Gross is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.